Short interest screen · refreshed after the Nov 12, 2026 close
Short squeeze monitor: Healthcare
Stocks with the largest share of their tradable float sold short. A high share of float sold short means many traders are betting on a decline. If the price rises instead, short sellers may need to buy shares to close their positions, which can add to the move. Days to cover shows how many average trading days that buying would take.
| # | Company | Price | Today | Short % float | Days to cover | Δ short int. | Short vol. 10d | Mkt cap |
|---|---|---|---|---|---|---|---|---|
| 1 | CCCCC4 TherapeuticsHealthcare | $2.77 | −4.15% | 47.3% | 15.1 | +9% | 48.0% | $363.7M |
| 2 | CAPRCapricor TherapeuticsHealthcare | $10.24 | −8.73% | 45.8% | 7.4 | −6% | 54.9% | $595.4M |
| 3 | NGNENeurogeneHealthcare | $23.90 | −4.78% | 44.2% | 17.0 | +12% | 63.8% | $494.8M |
| 4 | SPRYARS PharmaceuticalsHealthcare | $3.81 | −3.54% | 38.8% | 11.1 | −4% | 49.2% | $383.0M |
| 5 | NTLAIntellia TherapeuticsHealthcare | $10.55 | −7.54% | 38.6% | 11.1 | 0% | 48.3% | $1.48B |
| 6 | ZBIOZenas BioPharmaHealthcare | $27.64 | −3.69% | 36.4% | 24.1 | −9% | 59.1% | $1.87B |
| 7 | LENZLENZ TherapeuticsHealthcare | $4.09 | −0.49% | 36.3% | 5.6 | −22% | 49.7% | $128.5M |
| 8 | ABEOAbeona TherapeuticsHealthcare | $2.29 | −0.43% | 35.5% | 21.7 | −2% | 53.2% | $141.2M |
| 9 | INBXInhibrx BiosciencesHealthcare | $87.75 | −3.14% | 35.2% | 10.0 | −1% | 67.9% | $1.29B |
| 10 | WGSGeneDx HoldingsHealthcare | $51.87 | −5.90% | 34.9% | 7.3 | +9% | 61.1% | $1.55B |
| 11 | TNGXTango TherapeuticsHealthcare | $24.85 | −3.42% | 34.4% | 9.7 | +8% | 46.5% | $4.21B |
| 12 | RXRXRecursion PharmaceuticalsHealthcare | $3.33 | −7.24% | 32.9% | 6.1 | −12% | 50.2% | $2.08B |
| 13 | QTTBQ32 BioHealthcare | $8.82 | −4.13% | 32.3% | 12.1 | −1% | 59.6% | $263.9M |
| 14 | IBRXImmunityBioHealthcare | $6.07 | −9.00% | 32.0% | 10.8 | +3% | 61.4% | $6.46B |
| 15 | BEAMBeam TherapeuticsHealthcare | $24.03 | −6.90% | 31.8% | 13.7 | −1% | 63.3% | $2.49B |
| 16 | REPLReplimune GroupHealthcare | $21.98 | +0.92% | 31.4% | 8.3 | +6% | 52.2% | $2.08B |
| 17 | SMMTSummit TherapeuticsHealthcare | $15.08 | −9.40% | 30.5% | 9.4 | +3% | 54.0% | $12.06B |
| 18 | PRMEPrime MedicineHealthcare | $3.89 | −9.53% | 30.5% | 4.8 | −11% | 46.8% | $705.6M |
| 19 | NVAXNovavaxHealthcare | $8.76 | −12.22% | 29.5% | 7.6 | −2% | 53.0% | $1.45B |
| 20 | ASMBAssembly BiosciencesHealthcare | $20.18 | −9.79% | 29.2% | 17.0 | +4% | 59.4% | $410.9M |
| 21 | SLSSELLAS Life Sciences GroupHealthcare | $8.03 | −4.63% | 28.7% | 6.7 | +6% | 55.8% | $1.62B |
| 22 | ANABAnaptysBioHealthcare | $47.77 | −2.05% | 28.6% | 10.8 | −6% | 47.2% | $1.43B |
| 23 | GLUEMonte Rosa TherapeuticsHealthcare | $9.31 | −9.70% | 28.4% | 15.7 | +1% | 66.6% | $795.5M |
| 24 | CLYMClimb BioHealthcare | $10.87 | −11.27% | 27.7% | 7.8 | +8% | 62.0% | $638.5M |
| 25 | RLAYRelay TherapeuticsHealthcare | $18.08 | −8.32% | 27.7% | 20.7 | −1% | 54.6% | $3.99B |
| 26 | TMDXTransMedics GroupHealthcare | $92.00 | −0.01% | 27.6% | 10.2 | +1% | 52.3% | $3.20B |
| 27 | TYRATyra BiosciencesHealthcare | $19.77 | −5.75% | 27.6% | 15.3 | +4% | 71.2% | $1.37B |
| 28 | KODKodiak SciencesHealthcare | $108.25 | −1.00% | 27.4% | 9.3 | −5% | 52.8% | $6.80B |
| 29 | AQSTAquestive TherapeuticsHealthcare | $3.57 | −0.28% | 27.2% | 13.2 | +6% | 58.4% | $448.7M |
| 30 | OLMAOlema PharmaceuticalsHealthcare | $7.52 | −6.47% | 27.1% | 11.9 | +9% | 65.2% | $658.8M |
| 31 | LQDALiquidiaHealthcare | $58.12 | +5.27% | 26.5% | 5.3 | +1% | 53.7% | $5.24B |
| 32 | PGENPrecigenHealthcare | $4.66 | −1.27% | 26.2% | 8.6 | −3% | 46.1% | $1.67B |
| 33 | IMRXImmuneeringHealthcare | $3.67 | −3.17% | 26.1% | 19.2 | −11% | 42.4% | $237.7M |
| 34 | EDITEditas MedicineHealthcare | $2.14 | −10.08% | 26.0% | 17.6 | +1% | 61.2% | $330.3M |
| 35 | CELCCelcuityHealthcare | $64.17 | −0.23% | 25.9% | 5.9 | 0% | 63.8% | $3.14B |
| 36 | SRZNSurrozenHealthcare | $31.67 | −0.66% | 25.7% | 8.5 | +3% | 54.3% | $554.1M |
| 37 | DERMJourney MedicalHealthcare | $4.39 | −1.13% | 25.6% | 15.1 | +3% | 50.2% | $123.9M |
| 38 | LBRXLB PharmaceuticalsHealthcare | $42.46 | −5.03% | 25.6% | 18.0 | +11% | 54.9% | $1.37B |
| 39 | KYTXKyverna TherapeuticsHealthcare | $5.03 | −1.76% | 25.4% | 11.6 | −5% | 52.0% | $311.1M |
| 40 | HIMSHims & Hers HealthHealthcare | $19.73 | −5.19% | 25.3% | 5.8 | −3% | 59.2% | $4.62B |
| 41 | RAREUltragenyx PharmaceuticalHealthcare | $16.27 | −2.57% | 25.3% | 8.3 | +17% | 38.3% | $1.66B |
| 42 | GLSIGreenwich LifeSciencesHealthcare | $15.28 | −5.03% | 24.9% | 12.5 | +2% | 63.5% | $224.3M |
| 43 | CRVSCorvus PharmaceuticalsHealthcare | $10.62 | −7.41% | 24.1% | 18.9 | −1% | 56.8% | $895.8M |
| 44 | MPLTMapLight TherapeuticsHealthcare | $7.07 | −5.48% | 24.1% | 10.3 | −2% | 41.0% | $392.9M |
| 45 | FTHFaeth TherapeuticsHealthcare | $10.65 | −20.22% | 24.1% | 6.3 | +18% | 48.6% | $275.2M |
| 46 | ARCTArcturus Therapeutics HoldingsHealthcare | $8.44 | −9.34% | 23.8% | 7.4 | −1% | 62.7% | $243.3M |
| 47 | CTMXCytomX TherapeuticsHealthcare | $2.04 | −4.23% | 23.7% | 12.0 | +6% | 51.0% | $444.7M |
| 48 | IMMXImmix BiopharmaHealthcare | $8.07 | −6.81% | 23.6% | 9.2 | +5% | 55.6% | $669.0M |
| 49 | NUVBNuvation BioHealthcare | $4.06 | −5.36% | 23.5% | 12.5 | −2% | 54.1% | $1.43B |
| 50 | PVLAPalvella TherapeuticsHealthcare | $153.18 | −6.56% | 23.5% | 11.5 | +8% | 57.8% | $2.24B |
Data guard: 1 stock withheld — KPLT (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.